← FDA Drug Approvals (Drugs@FDA)

BACITRACIN ZINC AND POLYMYXIN B SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2002-02-27

Drug application

FDA Application #
ANDA065022
Application type
Abbreviated New Drug Application (Generic)
Brand name
BACITRACIN ZINC AND POLYMYXIN B SULFATE
Generic name
Bacitracin Zinc
Active ingredients
BACITRACIN ZINC; POLYMYXIN B SULFATE
Dosage form
OINTMENT
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
PADAGIS US
First approval
2002-02-27

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown